Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Radiation-killed bacteria can elicit T-cell immune response

Aug. 1, 2006

By Anette Breindl

Pandemic Planning: Not 'Out Of The Woods' Despite Good News

Aug. 1, 2006

By Anette Breindl

Radiation-Killed Bacteria Can Elicit T-Cell Immune Response

July 31, 2006

By Anette Breindl

Molecular Signature Of Aging Seen Across Tissues, Species

July 27, 2006

By Anette Breindl

Molecular Signature Of Aging Seen Across Tissues, Species

July 27, 2006

By Anette Breindl

Lung Cancer Kinase Target Goes Back To ADAM's Time

July 25, 2006

By Anette Breindl

Lung Cancer Kinase Target Goes Back To ADAM's Time

July 25, 2006

By Anette Breindl

Surprise Findings On Telomere Protection Genes, Mechanisms

July 21, 2006

By Anette Breindl

Surprise Findings On Telomere Protection Genes, Mechanisms

July 21, 2006

By Anette Breindl

New Antibody-Drug Combination Uses Therapeutic Role Reversal

July 14, 2006

By Anette Breindl

View All Articles by Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...